-
ICD-10-CM Codes
›
-
P00-P96
›
-
P00-P04
›
-
Newborn affected by noxious substances transmitted via placenta or breast milk P04
Newborn affected by noxious substances transmitted via placenta or breast milk P04-
Code FirstCode First Help
Certain conditions have both an underlying etiology and multiple body system manifestations due to the underlying etiology. For such conditions, ICD-10-CM has a coding convention that requires the underlying condition be sequenced first followed by the manifestation. Wherever such a combination exists there is a "use additional code" note at the etiology code, and a "code first" note at the manifestation code. These instructional notes indicate the proper sequencing order of the codes, etiology followed by manifestation. In most cases the manifestation codes will have in the code title, "in diseases classified elsewhere." Codes with this title are a component of the etiology/manifestation convention. The code title indicates that it is a manifestation code. "In diseases classified elsewhere" codes are never permitted to be used as first listed or principle diagnosis codes. They must be used in conjunction with an underlying condition code and they must be listed following the underlying condition.
- any current condition in newborn, if applicable
Type 2 ExcludesType 2 Excludes Help
A type 2 excludes note represents "not included here". A type 2 excludes note indicates that the condition excluded is not part of the condition it is excluded from but a patient may have both conditions at the same time. When a type 2 excludes note appears under a code it is acceptable to use both the code (P04) and the excluded code together.
- congenital malformations (Q00-Q99
ICD-10-CM Range Q00-Q99
Congenital malformations, deformations and chromosomal abnormalities- Q00-Q07 Congenital malformations of the nervous ...
- Q10-Q18 Congenital malformations of eye, ear, fa...
- Q20-Q28 Congenital malformations of the circulat...
- Q30-Q34 Congenital malformations of the respirat...
- Q35-Q37 Cleft lip and cleft palate
- Q38-Q45 Other congenital malformations of the di...
- Q50-Q56 Congenital malformations of genital orga...
- Q60-Q64 Congenital malformations of the urinary ...
- Q65-Q79 Congenital malformations and deformation...
- Q80-Q89 Other congenital malformations
- Q90-Q99 Chromosomal abnormalities, not elsewhere...
) - encounter for observation of newborn for suspected diseases and conditions ruled out (
ICD-10-CM Diagnosis Code Z05
- Z05 Encounter for observation and evaluation of n...
- Z05.0 Observation and evaluation of newborn for sus...
- Z05.1 Observation and evaluation of newborn for sus...
- Z05.2 Observation and evaluation of newborn for sus...
- Z05.3 Observation and evaluation of newborn for sus...
- Z05.4 Observation and evaluation of newborn for sus...
- Z05.41 Observation and evaluation of newborn for sus...
- Z05.42 Observation and evaluation of newborn for sus...
- Z05.43 Observation and evaluation of newborn for sus...
- Z05.5 Observation and evaluation of newborn for sus...
- Z05.6 Observation and evaluation of newborn for sus...
- Z05.7 Observation and evaluation of newborn for sus...
- Z05.71 Observation and evaluation of newborn for sus...
- Z05.72 Observation and evaluation of newborn for sus...
- Z05.73 Observation and evaluation of newborn for sus...
- Z05.8 Observation and evaluation of newborn for oth...
- Z05.9 Observation and evaluation of newborn for uns...
Z05.-) - neonatal jaundice from excessive hemolysis due to drugs or toxins transmitted from mother (
ICD-10-CM Diagnosis Code P58.4
Neonatal jaundice due to drugs or toxins transmitted from mother or given to newborn
2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
Code First- poisoning due to drug or toxin, if applicable (T36-T65 with fifth or sixth character 1-4 or 6)
Use Additional- code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)
P58.4) - newborn in contact with and (suspected) exposures hazardous to health not transmitted via placenta or breast milk (
ICD-10-CM Diagnosis Code Z77
- Z77 Other contact with and (suspected) exposures ...
- Z77.0 Contact with and (suspected) exposure to haza...
- Z77.01 Contact with and (suspected) exposure to haza...
- Z77.010 Contact with and (suspected) exposure to arse...
- Z77.011 Contact with and (suspected) exposure to lead...
- Z77.012 Contact with and (suspected) exposure to uran...
- Z77.018 Contact with and (suspected) exposure to othe...
- Z77.02 Contact with and (suspected) exposure to haza...
- Z77.020 Contact with and (suspected) exposure to arom...
- Z77.021 Contact with and (suspected) exposure to benz...
- Z77.028 Contact with and (suspected) exposure to othe...
- Z77.09 Contact with and (suspected) exposure to othe...
- Z77.090 Contact with and (suspected) exposure to asbe...
- Z77.098 Contact with and (suspected) exposure to othe...
- Z77.1 Contact with and (suspected) exposure to envi...
- Z77.11 Contact with and (suspected) exposure to envi...
- Z77.110 Contact with and (suspected) exposure to air ...
- Z77.111 Contact with and (suspected) exposure to wate...
- Z77.112 Contact with and (suspected) exposure to soil...
- Z77.118 Contact with and (suspected) exposure to othe...
- Z77.12 Contact with and (suspected) exposure to haza...
- Z77.120 Contact with and (suspected) exposure to mold...
- Z77.121 Contact with and (suspected) exposure to harm...
- Z77.122 Contact with and (suspected) exposure to nois...
- Z77.123 Contact with and (suspected) exposure to rado...
- Z77.128 Contact with and (suspected) exposure to othe...
- Z77.2 Contact with and (suspected) exposure to othe...
- Z77.21 Contact with and (suspected) exposure to pote...
- Z77.22 Contact with and (suspected) exposure to envi...
- Z77.29 Contact with and (suspected) exposure to othe...
- Z77.9 Other contact with and (suspected) exposures ...
Z77.-)
IncludesIncludes Help
"Includes" further defines, or give examples of, the content of the code or category.
- nonteratogenic effects of substances transmitted via placenta
Codes
- P04 Newborn affected by noxious substances transmitted via placenta or breast milk
- P04.0 Newborn affected by maternal anesthesia and analgesia in pregnancy, labor and delivery
- P04.1 Newborn affected by other maternal medication
- P04.11 Newborn affected by maternal antineoplastic chemotherapy
- P04.12 Newborn affected by maternal cytotoxic drugs
- P04.13 Newborn affected by maternal use of anticonvulsants
- P04.14 Newborn affected by maternal use of opiates
- P04.15 Newborn affected by maternal use of antidepressants
- P04.16 Newborn affected by maternal use of amphetamines
- P04.17 Newborn affected by maternal use of sedative-hypnotics
- P04.1A Newborn affected by maternal use of anxiolytics
- P04.18 Newborn affected by other maternal medication
- P04.19 Newborn affected by maternal use of unspecified medication
- P04.2 Newborn affected by maternal use of tobacco
- P04.3 Newborn affected by maternal use of alcohol
- P04.4 Newborn affected by maternal use of drugs of addiction
- P04.40 Newborn affected by maternal use of unspecified drugs of addiction
- P04.41 Newborn affected by maternal use of cocaine
- P04.42 Newborn affected by maternal use of hallucinogens
- P04.49 Newborn affected by maternal use of other drugs of addiction
- P04.5 Newborn affected by maternal use of nutritional chemical substances
- P04.6 Newborn affected by maternal exposure to environmental chemical substances
- P04.8 Newborn affected by other maternal noxious substances
- P04.81 Newborn affected by maternal use of cannabis
- P04.89 Newborn affected by other maternal noxious substances
- P04.9 Newborn affected by maternal noxious substance, unspecified